Non-small cell lung cancer+1
RecruitingStudy on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation
Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation
- Disease:Non-small cell lung cancerNon-small cell lung cancer metastatic
- Substances:BudesonideCarboplatin+4
Belgium- Participants:18–64 years · 65+ years
- Substances:Budesonide









